RRD Biopharma Development is a drug development company with an alternative approach to achieving human-proof-of-concept (hPOC) that is intensely focused on minimizing time, risk, and cost while maximizing efficiency and probability of success. RRD’s Product Development Team (PDT) model is ideal for companies interested in an asset-centric capital approach that can accelerate an hPOC value inflection as efficiently as possible while enabling the development of hig- quality, pharmaceutical-grade data packages required by regulators and potential biopharma partners. The PDT model provides our partners with a “plug and play”, high-caliber, and highly experienced drug development team that can be deployed immediately. Time and resources are not needlessly spent assembling the right development team or enduring consultant hand-offs on the front end, which can absorb 18 months or more, with no guarantee of coalescence, while impacting exclusivity and revenue on the back end. Paying for this learning curve is expensive. Together with our partners, we tailor strategies designed to optimize product value to a defined stage of development and then direct and manage execution of that strategy towards optimizing outcomes. Learn more about us at www.rrdbiodev.com